Ertugliflozin Alternatives Compared
| Ertugliflozin | Rybelsus (semaglutide) | Mounjaro (tirzepatide) |
|
|---|
| Ertugliflozin | Rybelsus (semaglutide) | Mounjaro (tirzepatide) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Type 2 Diabetes. Ertugliflozin may also be used for purposes not listed in this medication guide. |
Prescription only
Rybelsus (semaglutide) is an oral medicine that can be used as a first-line medication to improve blood sugar control in adults over the age of 18 with type 2 diabetes. It works by mimicking the... View more |
Prescription only
Prescribed for Weight Loss (Obesity/Overweight), Type 2 Diabetes. Mounjaro may also be used for purposes not listed in this medication guide. |
Related suggestions Type 2 Diabetes
|
|||||||||||||||
| More about Ertugliflozin | More about Rybelsus (semaglutide) | More about Mounjaro (tirzepatide) | ||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||
|
Ertugliflozin has an average rating of 5.1 out of 10 from a total of 13 ratings on Drugs.com. 38% of reviewers reported a positive effect, while 38% reported a negative effect. |
Rybelsus has an average rating of 6.4 out of 10 from a total of 312 ratings on Drugs.com. 49% of reviewers reported a positive effect, while 22% reported a negative effect. |
Mounjaro has an average rating of 8.5 out of 10 from a total of 1450 ratings on Drugs.com. 79% of reviewers reported a positive effect, while 6% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||
|
View all Ertugliflozin side effects |
View all Rybelsus side effects |
View all Mounjaro side effects |
||||||||||||||||
| Drug Class | ||||||||||||||||||
| Generic Availability | ||||||||||||||||||
|
N/A |
||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Rybelsus prices |
View all Mounjaro prices |
||||||||||||||||
| Dosage Forms | ||||||||||||||||||
|
N/A |
|
|
||||||||||||||||
| Brand Names | ||||||||||||||||||
| Steglatro | Other semaglutide brands include: Ozempic, Wegovy | Other tirzepatide brands include: Zepbound | ||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||
|
16.6 hours |
168 hours |
120 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | ||||||||||||||||||
|
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | ||||||||||||||||||
|
A total of 371 drugs are known to interact with Ertugliflozin:
|
A total of 275 drugs are known to interact with Rybelsus:
|
A total of 416 drugs are known to interact with Mounjaro:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
||||||||||||||||||
| Disease Interactions | ||||||||||||||||||
| First Approval Date | ||||||||||||||||||
|
December 19, 2017 |
September 20, 2019 |
N/A |
||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||
| More Information | ||||||||||||||||||
| Patient Resources | ||||||||||||||||||
| Professional Resources | ||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.